We review the model following a change of analyst and allow for the H1-2025 guidance

08/10/25 -"The company has issued no guidance on EPS, but earnings are expected to remain negative in 2025 and 2026. The earnings outlook has been downgraded following a c.-22% decline in Adj. EBITDA in the ..."

Executive summary
Conflict of interest

Pages

Language

English

Published on

08/10/25

Download

You may also be interested by these reports :

08/10/25

Worldline

The company has issued no guidance on EPS, but earnings are expected to remain negative in 2025 and 2026. The earnings outlook has been downgraded ...

03/10/25

GBL

GBL announced that it has entered into exclusive negotiations to sell the majority of its third-party AM arm, quite a surprise given the latest ...

02/10/25

Partners Group

Change in coverage

26/09/25

Exor

Exor posts a modest NAV uptick, yet the lift owes more to share buybacks than portfolio strength. Liquidity is at record levels, but the path ahead ...

EXECUTIVE SUMMARY

Updates

Pension Risks

Target & Opinion

Governance & Management

Business & Trends

Graphics : Momentum

Money Making

Graphics : MACD & Volumes

Debt

Graphics : Sensitivities

Valuation

Sector: Performance

DCF

Sector: Key data

NAV/SOTP

Sector: Ratios & Valorisation

Worth knowing

Sector: Peers

Financials

Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking

Trading in corporate shares

Analyst ownership

Advising of corporate (strategy, marketing, debt, etc)

Research paid for by corporate

Provision of corporate access paid for by corporate

Link between and a banking entity

Brokerage activity at AlphaValue